Definition of supertypes for HLA molecules using clustering of specificity matrices
- 1k Downloads
Major histocompatibility complex (MHC) proteins are encoded by extremely polymorphic genes and play a crucial role in immunity. However, not all genetically different MHC molecules are functionally different. Sette and Sidney (1999) have defined nine HLA class I supertypes and showed that with only nine main functional binding specificities it is possible to cover the binding properties of almost all known HLA class I molecules. Here we present a comprehensive study of the functional relationship between all HLA molecules with known specificities in a uniform and automated way. We have developed a novel method for clustering sequence motifs. We construct hidden Markov models for HLA class I molecules using a Gibbs sampling procedure and use the similarities among these to define clusters of specificities. These clusters are extensions of the previously suggested ones. We suggest splitting some of the alleles in the A1 supertype into a new A26 supertype, and some of the alleles in the B27 supertype into a new B39 supertype. Furthermore the B8 alleles may define their own supertype. We also use the published specificities for a number of HLA-DR types to define clusters with similar specificities. We report that the previously observed specificities of these class II molecules can be clustered into nine classes, which only partly correspond to the serological classification. We show that classification of HLA molecules may be done in a uniform and automated way. The definition of clusters allows for selection of representative HLA molecules that can cover the HLA specificity space better. This makes it possible to target most of the known HLA alleles with known specificities using only a few peptides, and may be used in construction of vaccines. Supplementary material is available at http://www.cbs.dtu.dk/researchgroups/immunology/supertypes.html.
KeywordsHLA Supertype Classification Class I Class II
This work is part of the IHWG and was supported by the Danish National Research Foundation, the Danish MRC (grant 22-01-0272), the 5th Framework Programme of the European Commission (grant QLRT-1999-00173), NIH (grant AI49213-02) and the Bioinformatic Program of the Dutch Science Foundation (NWO PGBMI 015).
- Cover TM, Thomas JA (1991) Elements of information theory. Wiley, New YorkGoogle Scholar
- Guercio MF del, Sidney J, Hermanson G, Perez C, Grey HM, Kubo RT, Sette A (1995) Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J Immunol 1995 154:685–693Google Scholar
- Ishioka GY, Fikes J, Hermanson G, Livingston B, Crimi C, Qin M, del Guercio MF, Oseroff C, Dahlberg C, Alexander J, Chesnut RW, Sette A (1999) Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes. J Immunol 162:3915–3925PubMedGoogle Scholar
- Lyngs, Pedersen CN, Nielsen HR (1999) Metrics and similarity measures for hidden Markov models. Proc Int Conf Intell Syst Mol Biol:178–186Google Scholar
- Marsh SGE, Parham P, Barber LD (2000) The HLA facts book. Academic Press, LondonGoogle Scholar
- Nielsen M, Lundegaard C, Worning P, Lauemr SL, Buus S, Brunak S, Lund O (2004) Improved prediction of MHC class II epitopes using a Gibbs sampling approach. Bioinformatics (in press)Google Scholar
- Press WH, Flannery BP, Teukolsky SA, Vetterling, WT (1992) Numerical recipies in C. Cambridge University Press, CambridgeGoogle Scholar
- Rodriguez F, An LL, Harkins S, Zhang J, Yokoyama M, Widera G, Fuller JT, Kincaid C, Campbell IL, Whitton JL (1998) DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. J Virol 72:5174–5181PubMedGoogle Scholar
- Sturniolo T, Bono E, Ding J, Raddrizzani L, Tuereci O, Sahin U, Braxenthaler M, Gallazzi F, Protti MP, Sinigaglia F, Hammer J (1999) Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol 17:555–561PubMedGoogle Scholar